Inventor · disambiguated record
Michael Vincent Mccullar
Also filed as: MCCULLAR MICHAEL VINCENT
1 granted patent·4 pending applications·8 citations·filing 2019–2021
31Inventor score
Files withSUMITOMO PHARMA ONCOLOGY INC3SUMITOMO DAINIPPON PHARMA ONCOLOGY INC1TOLERO PHARMACEUTICALS INC1
Top patents by PatentIndex Score
5 records- 0187US11793802B2Treatment of acute myeloid leukemia (AML) with venetoclax failureSUMITOMO PHARMA ONCOLOGY INC·Filed 2020·Granted Oct 24, 2023·8 cites·20 claims
- 0261US2022339172A1Methods for treating castration-resistant and castration-sensitive prostate cancerSUMITOMO PHARMA ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0349US2020281949A1Methods for treating castration-resistant and castration-sensitive prostate cancerTOLERO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0448US2024382473A1Combination Therapies for Treatment of Myelodysplastic SyndromeSUMITOMO PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0544US2022257581A1Treatment of CancerSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Vincent Mccullar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →